The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

At issue is the role pharmacy benefit mangers play in taking large discounts on drugs that advocates say are not passed along ...

The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...

A key provision in the new legislation could affect compensation for brokers or consultants who help employers hire pharmacy ...